Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models
Abstract Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Among the key challenges in developing effective therapeutics is the poor translation of preclinical models used in the drug discovery pipeline. This leaves drug attrition rates and costs at an unacceptably high level....
Guardado en:
Autores principales: | Melica Nourmoussavi Brodeur, Kayla Simeone, Kim Leclerc-Deslauniers, Hubert Fleury, Euridice Carmona, Diane M. Provencher, Anne-Marie Mes-Masson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8cf5cb2dcdec424aabc6b0c6535c4a57 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety evaluation of the mouse TCRα - transduced T cell product in preclinical models in vivo and in vitro
por: Anastasiia Kalinina, et al.
Publicado: (2022) -
Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
por: Hubert Fleury, et al.
Publicado: (2019) -
Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion
por: Kossay Zaoui, et al.
Publicado: (2019) -
The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems
por: Nagasuryaprasad Kotikalapudi, et al.
Publicado: (2021) -
Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems
por: Nagasuryaprasad Kotikalapudi, et al.
Publicado: (2021)